
Record Q2 at CME
Chairman Terry Duffy said a contributor to this growth has been a continuing shift in the global derivatives landscape "as users are increasingly focused on credit quality and cognisant of the appeal of transparent, exchange-traded instruments with central counterparty clearing."
CME’s net revenues increased 32% to $142 million for Q2 this year, compared with $108 million for the same period in 2002. Average daily volume increased 23% year-on-year to nearly 2.7 million contracts for Q2 2003.
CME
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact customer services - www.fx-markets.com/static/contact-us, or view our subscription options here: https://subscriptions.fx-markets.com/subscribe
You are currently unable to print this content. Please contact customer services - www.fx-markets.com/static/contact-us to find out more.
You are currently unable to copy this content. Please contact [email protected] to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email [email protected]
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email [email protected]